Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 06, 2007 16:05 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Completes $60 Million Note Offering Secured by Argatroban Royalties

HOUSTON, Feb. 6, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that its newly formed, wholly-owned subsidiary has closed a private placement of $60 million in...
February 05, 2007 16:35 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Presentation/Webcast At BIO CEO Conference

HOUSTON, Feb. 5, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it will participate in the 9th Annual BIO CEO & Investor Conference, taking place February...
January 30, 2007 08:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Conference Call to Discuss Fourth Quarter and Year End 2006 Results

HOUSTON, Jan. 30, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) will hold an investor conference call on Friday, March 9, 2007 at 8:00 a.m. ET to discuss its fourth quarter and year...
January 04, 2007 08:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Presentation/Webcast At 25th Annual JPMorgan Healthcare Conference

HOUSTON, Jan. 4, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it will participate in the 25th Annual JPMorgan Healthcare Conference, taking place January 8-11,...
December 28, 2006 13:53 ET | Source: Encysive Pharmaceuticals Inc.

FDA Accepts Encysive's Complete Response to THELIN New Drug Application

HOUSTON, Dec. 28, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's complete...
December 18, 2006 02:30 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Launch of Thelin in Germany

HOUSTON, Dec. 18, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets are now commercially available in Germany for...
December 15, 2006 13:47 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals' THELIN (sitaxentan sodium) Receives Positive Opinion From Australian Health Authority

HOUSTON, Dec. 15, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that the Australian Drug Evaluation Committee (ADEC) of the Therapeutic Goods Administration (TGA)...
December 14, 2006 21:03 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Submits Response to FDA For Thelin New Drug Application

HOUSTON, Dec. 14, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced it has provided the information requested by the U.S. Food and Drug Administration (FDA) in its letter...
December 14, 2006 08:35 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Expects to Submit Revised Response to Thelin Approvable Letter Within Several Days

HOUSTON, Dec. 14, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) announced today that the U.S. Food and Drug Administration (FDA) informed the Company that its response to the...
December 07, 2006 18:45 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Receives FDA Clearance to Resume Clinical Studies With TBC3711

HOUSTON, Dec. 7, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to initiate and resume...